论文部分内容阅读
今年 ASCO会议上报告的血液肿瘤临床研究论文较多，以下主要对非霍奇金氏淋巴瘤（ NHL）、白血病及癌症病人的血液支持治疗的一些进展作简单综述。 1 NHL治疗的新方法 复发性 NHL用常规的治疗方法难以治愈。大剂量化疗和加干细胞移植可治愈部分复发的、恶性程度较高的淋巴?
There are many clinical research papers on hematologic neoplasms reported at this year’s ASCO meeting. The following is a brief review of some of the advances in blood support therapy for non-Hodgkin’s lymphoma (NHL), leukemia and cancer patients. A new approach to NHL treatment Recurrent NHL is difficult to cure with conventional treatments. High-dose chemotherapy and stem cell transplantation can cure partially relapsed, highly malignant lymph nodes.